Evidence mapPaperPMID 40500129Full record

ReviewEuropean respiratory review : an official journal of the European Respiratory Society2025

Moderate-to-late prematurity: understanding respiratory consequences and modifiable risk factors.

Kishan D Tsang, Gerdien A Tramper-Stranders, Jasper V Been, Angelique K Hoffmann-Haringsma, Irwin K Reiss, Marielle W H Pijnenburg, Ismé M De Kleer

Abstract readReview
In one paragraph

Review in European respiratory review : an official journal of the European Respiratory Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kishan D TsangDepartment of Paediatrics, Franciscus Gasthuis and Vlietland, Rotterdam, The Netherlands k.tsang@franciscus.nl.
Gerdien A Tramper-StrandersDepartment of Paediatrics, Franciscus Gasthuis and Vlietland, Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0002-0228-5375
Jasper V BeenDepartment of Paediatrics, Division of Neonatal and Paediatric Intensive Care, Erasmus University Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0002-4907-6466
Angelique K Hoffmann-HaringsmaDepartment of Paediatrics, Franciscus Gasthuis and Vlietland, Rotterdam, The Netherlands.
Irwin K ReissDepartment of Paediatrics, Division of Neonatal and Paediatric Intensive Care, Erasmus University Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands.
Marielle W H PijnenburgDepartment of Paediatrics, Division of Respiratory Medicine and Allergology, Erasmus University Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands.
Ismé M De KleerDepartment of Paediatrics, Franciscus Gasthuis and Vlietland, Rotterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As survival rates of preterm infants have increased due to advances in perinatal care, focus has shifted towards the profound long-term effects of prematurity. An extensive amount of evidence has shown increased susceptibility to chronic illnesses among preterm infants. While the onset of such conditions typically emerges during adulthood, their roots trace back to the early stages of life. Much of this interest has been directed towards short- and long-term consequences of extreme and very preterm birth. However, it has become apparent that, despite a limited risk of complications during the neonatal period, the moderate and late preterm population suffers from an increased likelihood of morbidity during the course of life. Considering the higher prevalence of moderate and late preterm births compared to extreme and very preterm births, understanding and investigating their health outcomes is essential to address the broader impact of prematurity. In this review, we will discuss the impact of moderate and late prematurity on lung development, function and how environmental factors impose these individuals to increased risk for respiratory morbidity during the course of life. We describe interventions during early life that may protect the moderate-to-late preterm population from adverse lung development and further deterioration by addressing modifiable risk factors.

Indexed as

Infant, PrematureLungPremature BirthAge FactorsGestational AgeHumansInfant, NewbornPrognosisRisk AssessmentRisk FactorsTime Factors

Identifiers

PMID40500129
PMCPMC12152585

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.